David Kenley - holds a 6.9% interest in Calzada Ltd, which fully owns Metabolic Pharmaceuticals Pty Ltd. Evert Vos - is a Consultant to Metabolic Pharmaceuticals Pty Ltd. He was previously the Medical Director of the company responsible for all of the human clinical trials. Heike Stier is an employee of analyze and realize ag and has written this manuscript. Analyze and realize ag acts as an consultant to Metabolic Pharmaceuticals Pty Ltd in relation to possible novel food applications in the European region.
Resting plasma concentrations (mean±SEM) of mature ANP and Nt‐proANP were 14±2 pg/mL and 4±0.6 pg/mL at baseline. After gastric bypass surgery, the resting plasma concentrations rose to 24±5 pg/mL and 7±0.7 pg/mL for ANP and Nt‐proANP (increased by 23% and 43%), respectively (P=0.016 and 0.008). Absolute concentrations of ANP and Nt‐proANP were higher in individuals after bypass surgery at all acute time points during and after administration of intravenous saline (Figure 1A and 1B; P<0.001). A secondary analysis, adjusted for age, sex, and mean arterial pressure yielded similar results.
Apidren has jumped to the top of the ratings in just about every category as the #1 diet supplement! Recognized by ConsumerPriceWatch as the most powerful diet supplements on the market for close to a decade, this all-natural formula makes controlling your appetite and regaining your confidence as easy as possible. With the results users are seeing from Apidren, we were not surprised to see Apidren has the highest re-order rate. Apidren has dominated the effectiveness and ingredient ratings because of its unique ingredients. They are clinically proven to reduce BMI, decrease body fat, shrink waistline, and deliver significant weight loss.

One combination of natural supplements that boost IGF-1 with no injections required would simply be a one-two combo of whey protein and colostrum. Throw small bits of natural dairy into the mix and you’ve got a pretty potent trilogy for not just increasing IGF-1, but also all the fat loss, lean muscle gain, and cellular repair mechanisms that accompany a surge in growth hormone.
An OGTT was performed at screening and after 12 and 24 weeks of treatment. At these visits blood samples for assessment of glucose and insulin were collected immediately prior to and 2 hours after an oral glucose load. After 12 weeks the overall change in pre-load glucose was -0.02 units and there were no significant differences between the randomized treatment groups (P = 0.73488). The changes in pre-load glucose in the placebo group differed by -0.08, -0.06, and -0.07 units from those obtained in the AOD9604 0.25 mg, 0.5 mg, and 1 mg treatment groups, respectively; none of these differences were statistically significant. Similar results have been obtained after 24 weeks of treatment. The overall change in pre-load glucose after 24 weeks treatment was 0.04 units, and there were no significant differences among the treatment groups (P = 0.62787). Estimated differences from placebo in change in pre-load glucose were -0.03, 0.02, and 0.06 units for the AOD9604 0.25 mg, 0.5 mg, and 1 mg treatment groups, respectively; none of these differences were statistically significant.
If you are interested in using fat loss supplements to assist in your weight loss journey but have never used peptides before, don’t worry, our clinic doctor is available to answer any of your questions. To discuss any concerns, simply email your questions to info@musclepeptides.com.au and our doctor and professional team will get back to you so you can be one step closer to starting your weight loss journey. Want to find out more information right now? Why not see if your questions have already been answered in our FAQs?
Getting enough sleep is essential to feeling good – and losing weight. “It’s not so much that if you sleep, you will lose weight, but if you are sleep-deprived, meaning that you are not getting enough minutes of sleep or good quality sleep, your metabolism will not function properly,” explains Michael Breus, PhD and the clinical director of the sleep division for Arrowhead Health in Glendale, Ariz.
Ipamorelin is a man-made peptide that is part of the growth hormone family. Rated as one of the safest in the peptide industry, it has strong growth hormone releasing properties. From this, it is a huge winner with athletes and bodybuilders. This is because it builds muscle and keeps weight down quickly. It works by sending signals to the pituitary gland at the base of the brain and adjusts and controls various body functions through the endocrine system. It binds certain receptors inside cells. This allows cells to respond and change, encouraging growth and regulation of hormones. Ipamorelin can help with:
Hey Elvia, do you think that using DAC for short periods of time at your proposed dose is still effective for fat loss? Say for four weeks at 4mg a week? I know peptides need to be used for awhile before effect can be seen. I was thinking about doing 4mg a week for 4 weeks with Injectable l-carnitine for my last 4 weeks before summer haha. In your experience is it worth it to spend the money on the DAC for such a short period?
However, after the administration, Mod GRF 1-29 starts breaking down soon. This happens because peptides have a strong affinity for bonding with amino acids. The administered peptide has to travel a long distance between the point of administration and the pituitary gland. On the way, the enzymes act on it making it break down and bond with the amino acids. The peptides that are secreted by the body on its own do not have to face this problem because they do not have to travel this long.

Another way GH helps with fat loss is that it maintains blood glucose levels by inhibiting glucose uptake into peripheral cells, decreasing glucose oxidation for energy in the cells, and therefore increasing glucose production in cells from fat and amino acids (gluconeogenesis) (Copeland 1994, Ho 1996). The free fatty acids in the blood from lipolysis also partially block the insulin receptors on cell membranes, decreasing the effectiveness of insulin in triggering the removal of glucose from the blood, causing insulin resistance, or decreased insulin sensitivity. These all result in fat loss, especially from hard to move intra-abdominal fat stores (Johannsson 1997).
From this study it appears that the β3-AR is an important contributor to the effects observed on body weight in obese mice treated with AOD9604 and hGH. To determine whether theβ 3-AR is partly responsible for this effect, we examined the effects of AOD9604 and hGH in theβ 3-KO mouse. The β3-KO mouse is not grossly obese, but female mice have increased fat depots (21) and the mice do develop late-onset obesity (Summers, R. J., personal communication). AOD9604 and hGH increased body mass and decreased BAT mass in the WT strain but had no effect in the KO animals. In WT mice, plasma glycerol was increased in response to AOD9604 and hGH treatment (4 wk). However, in the KO mice, only hGH resulted in increased levels of glycerol in the KO mice, and this effect was significantly less than that observed in the WT mice. This suggests that the regulation of the β3-AR is essential in the ability of AOD9604 and hGH to mediate chronic effects on lipolysis and fat mass reduction.

In summary, we found that weight loss in obese individuals undergoing gastric bypass surgery is associated with higher natriuretic peptide concentrations across a range of loading conditions. This observation is consistent with a higher “set point” of natriuretic peptide levels after weight loss. That these findings are accompanied by improvements in blood pressure, heart rate and echocardiographic diastolic function provides persuasive evidence that the increase in natriuretic peptides with weight loss is “primary” and not secondary to alterations in cardiac structure or function.
The effect of AOD9604 and hGH on β3-ARs in adipose tissue is believed to be a direct action of these compounds and not an effect secondary to the fat metabolism, given that both AOD9604 and hGH can influence β3-AR expression and function in a nonadipocyte human cell line (11). Hence, the β3-AR appears to be necessary for the chronic effectiveness of AOD9604 on lipolysis in BAT.
I’m 50 and have been using CJC-1295+Ipamorelin Combo for almost 1 year now. Yes with 2 rest periods. Very very happy with the results. Skin is smoother / softer to touch reduced bags under my eyes, my wife loves the new feel. I train 5 days a week and the increase in muscle volume and tone is very noticeable. I will say however it is a slow steady natural looking increase. Recovery is great and I think it is helping with injury repair, as i have a problem Knee that is feeling alot better ever since I’ve been on this product. As you can see the cost is high but if there were no outstanding results my wife would say I was a Di#*head, but she is encouraging me to continue. Train hard, eat well and look better. Use CJC-1295+Ipamorelin Combo. I do
Ipamorelin is very similar to the growth hormone releasing peptides (GHRPs) GHRP 2 and GHRP 6 in that it mimics ghrelin (the hunger hormone) and targets a specific HGH pulse. However, unlike other GHRPs, this peptide doesn’t affect the release of cortisol, acetylcholine, prolactin and aldosterone thereby minimizing side effects experienced with other GH therapies, such as increased hunger. Because there are virtually no negative side effects, Ipamorelin can be prescribed more aggressively and more frequently than other therapies without the risk of elevated cortisol and acetylcholine blood plasma levels. This helps optimize HGH levels for a longer period of time, leading to more successful health outcomes.
Yes, Ipamorelin can help you lose weight. But, if you are not exercising, and aren’t eating well, it can only do so much. There is no magical supplement which will undo laziness and a horrible diet – keep this in mind. When using it for fat loss, make sure you are exercising. Doing so will naturally increase weight loss results, as you are going to burn more calories, along with the caloric deficit you are already on, for greater results. Further, your diet matters. If you are eating 5000 calories of junk per day, no supplement will help you lose weight – no matter how potent it claims to be!
It has to be noted that three of the SAEs were skin cancer forms. Since the study was performed in Australia, a country with the highest incidence rate of skin cancer (http://globocan.iarc.fr/), this cumulative incidence is not improbable. Furthermore the study was performed on clinically obese subjects with a BMI ≥ 35 kg/m2 (BMI ≥ 35 kg/m2; Median BMI: 40 kg/m2, range: 35 to 67 kg/m2). It is known that the incidence of several types of cancers is associated with increased BMI [26].
Within all the clinical trials the subjects received either the active treatment AOD9604 Tyr-hGH177-191(Metabolic Pharmaceuticals Ltd.; amino acid sequence: YLRIVQCRSVEGSCGF; CAS Registry Number: 38624-39-7; INCI Name: 27701 sh-Oligopeptide-74) or placebo (vehicle of mix of excipients). In addition, in study METAOD001 individual subjects were treated with rhHG (0.12 IU/kg; supplied by Unichem in the form of somatropin (Saizen® - Serono)) as a positive control. The administered doses of the study product ranged from 25 µg up to 400 µg per kg bodyweight for the injectable product (i.v. administration in study METAOD001 and METAOD002) and from 0.25 mg/day to 54 mg/day for the orally administered capsules/tablets (capsules METAOD003 - METAOD005; tablets: METAOD006).
The consumption of all dairy products have been shown to naturally raise IGF-1 levels , but I personally go straight to the source and both drink camel milk and other forms of raw milk (in moderation) and use goat’s milk colostrum. In scientific studies, colostrum supplements have proven to increase the amount of IGF-1 and IgA in the bloodstream (IgA is an important immunoglobulin that helps to ensure our immunity to pathogens, especially in the mucous membranes).
CJC-1295 is a fast-acting Growth Hormone Releasing Hormone designed to enhance the body’s natural production and release of human growth hormone and Insulin-like Growth Factor 1 (IGF-1). In doing so, CJC-1295 reverses the age-related decline, generates new muscle cells and increases fat loss. Another great trait of CJC-1295 is its ability to promote slow wave sleep, a deep sleep responsible for the highest levels of cell regeneration, muscle growth and memory retention.

Tβ4 has been used at our clinic with a great deal of success in patients suffering from Lyme disease or other infectious and/or inflammatory conditions. Tβ4 is very well tolerated and has not been found to cause any significant side effects. It can be taken on its own or in conjunction with an existing therapy, making it a versatile and valuable drug.
Results: AOD9604 had no effect on serum IGF-1 levels, which confirms the hypothesis that AOD9604 does not act via IGF-1. Results of oral glucose tolerance test demonstrated that, in contrast with hGH, AOD9604 has no negative effect on carbohydrate metabolism. There were no anti-AOD9604 antibodies detected in any of the patients selected for antibody assay. In none of the studies did a withdrawal or serious adverse event occur related to intake of AOD9604.

Ipamorelin is very similar to the growth hormone releasing peptides (GHRPs) GHRP 2 and GHRP 6 in that it mimics ghrelin (the hunger hormone) and targets a specific HGH pulse. However, unlike other GHRPs, this peptide doesn’t affect the release of cortisol, acetylcholine, prolactin and aldosterone thereby minimizing side effects experienced with other GH therapies, such as increased hunger. Because there are virtually no negative side effects, Ipamorelin can be prescribed more aggressively and more frequently than other therapies without the risk of elevated cortisol and acetylcholine blood plasma levels. This helps optimize HGH levels for a longer period of time, leading to more successful health outcomes.
In total 118 AEs were reported. No SAEs were reported. The most common adverse event reported by 16/23 subjects (69.6%) was mild or moderate headache. From all the reported AEs three events were reported of severe intensity (one in the 50 µg/kg AOD9604 group, 2 in the placebo group), with one of those events (a feeling of chest tightness) deemed possibly related to the AOD9604 treatment. Mild or moderate euphoria deemed possibly related to treatment, was reported by 5/23 subjects, during the periods when the AOD9604 was administered. There were no reports of euphoria during placebo administration. In total, there was no observable trend between the different treatment groups with respect to the incidence of certain AEs.

The β3-AR and actin primers were intron spanning to potentially reveal contaminant genomic DNA (none observed). Reverse primers were labeled before the PCR in a reaction mixture containing 120 pmol oligonucleotide, 70 μCi[γ -33P]ATP (Bresagen, Adelaide, Australia), 1× One-Phor-All Plus buffer (Pharmacia Biotech, Uppsala, Sweden) and 20 U T4 polynucleotide kinase (Pharmacia Biotech) in a volume of 40 μl. Following incubation at 37 C for 30 min, reactions were diluted to 100 μl with H2O and heated at 90 C for 2 min.

Twelve WT and 11 β3-KO male mice aged between 12 and 14 wk were used in the chronic administration study. The animals were housed individually in cages under the conditions described above. The animals were divided into three groups: WT [control (saline; n = 3); AOD (250 μg/kg·d; n = 4) and hGH (1 mg/kg·d; n = 5)] and β3-KO [control (saline; n = 3); AOD (250 μg/kg·d; n = 4); and hGH (1 mg/kg·d; n = 4)]. On d 0, all animals were anesthetized with sodium pentobarbitone and a collection of blood (200 μl) was taken in heparinized tubes (Terumo, Somerset, NJ) for glycerol determination. The plasma was isolated by centrifugation and stored at −20 C until required for analysis. For the following 28 d, the animals were given a single ip dose of compound at 0800 h each morning. Their food intake and body weight were recorded every second day and results expressed as a change from d 0. On d 28, the animals were anesthetized with sodium pentobarbitone, blood was collected for plasma glycerol determination, and they were then killed by a lethal injection of sodium pentobarbitone to the heart (35 mg/kg). Their white epididymal and brown subscapular adipose tissues were collected and weighed.
Various experiments have been conducted to test the effectiveness of CJC 1295-DAC in vivo and the Journal of Clinical Endocrinology & Metabolism has reported dose-dependent increases in mean plasma GH concentrations by 2-10 fold for more than 6 days and increased IGF-1 concentrations 1.5-3 fold for 9-11 days after a single injection. Mean half-life was shown to be 5.8-8.1 days, also after multiple doses mean IGF-1 levels remained above baseline for up to 28 days. No serious adverse reactions were reported in any group.
As both CJC1295 and Ipamorelin bind to the pituitary gland and prompt the release of GH, when used together, the production of growth hormone is over 10 times more than when used individually. As it stimulates the body’s natural growth hormone production it also causes the release of IGF-1. The advantages of the CJC peptide is that it helps increases bone density and collagen, as well as boosting the immune system. It will also produce new muscle cells which will be leaner and increases weight loss. The CJC 1295 results are part of years of scientific studies. It primarily increases the production of proteins, which leads to stable bodily functions related to the glands in the body or the endocrine system.
For those who are just getting started, make sure you go gradually. Start off with an eight-week cycle, and start off with 200 mcg (rather than 300) per day. Doing a test run will allow you to see how your body is going to react. If all goes well, you can then increase your dosage cycle to an 8 to 12 week period, and possibly add an additional injection dose daily, or increase to 300 mcg with each use.
There are different things you have to consider when wanting to purchase peptides on the web. In the event that you would prefer not to squander your time and cash and hazard your life to get low quality peptides, dependably settle with the most solid and legitimate peptide provider as this can have a gigantic effect. In the event that despite everything you can’t locate a decent provider of first rate quality peptides, you can request your other’s proposals. You may likewise look at PEPTIDE CLINICS in the event that you need.
Conclusions: Subcutaneous administration of CJC 1295 resulted in sustained, dose-dependent increases in GH and IGF-I levels in healthy adults and was safe and relatively well tolerated, particularly at doses of 30 or 60 ug/ kg. There was evidence of a cumulative effect after multiple doses. These data support the potential utility of CJC 1295 as a therapeutic agent.
Our Privacy Policy includes important information about our collection, use and disclosure of your personal information (including to provide you with targeted advertising based on your online activities). It explains that if you do not provide us with information we have requested from you, we may not be able to provide you with the goods and services you require. It also explains how you can access or seek correction of your personal information, how you can complain about a breach of the Australian Privacy Principles and how we will deal with a complaint of that nature.
Press coverage and word of mouth has generated quite a bit of hype around AOD9604. Despite its popularity on the black market, there is no research into the safety and effect of injecting this peptide at high doses. Intriguingly, it is not currently in Calzada's interest to fight the black market production of AOD9604, even though it is a patented product. Calzada lack the funds to legitimately boost the reputation of this peptide through clinical trials, and there is a strong chance these would once again prove that AOD9604 has no effect. The good reputation this peptide currently enjoys is likely to provide strong leverage to its marketing as a food supplement in the United States.

There is evidence of involvement of organised crime in supply of the substances. The substances are offered for sale via the internet. Many of the substances are promoted as safe alternatives to traditional performance enhancing substances such as the anabolic steroids. Suppliers are making unproven assertions about the efficacy and safety of the substances.
What may be unknown to some people is that hormones can come in three classes. We are all familiar with steroid hormones, which are fat soluble hormones that include testosterone, oestrogen, and their derivatives. A lesser known group of hormones are those made from peptides. The best known peptide hormone is human growth hormone (hGH) and insuline-like growth factor 1 (or IGF1), both of which are anabolic hormones that are responsible for cell growth and proliferation. Finally, some single amino acid derivatives can also be classed as hormones. Amino acids such as phenylalanine, tyrosine, and tryptophan can also be biologically modified into hormones.
Melanotan II: A synthetic hormone, originally developed to protect against sunlight and theoretically reduce the incidence of sun cancer, Melanotan II has also be found to stimulate male erections. Anecdotally, users report weight loss when using melanotan II and there is experimental evidence to suggest that melanotan II sends signals to the brain that the body is full. Reports of harm are rare, though it has been known to break down muscle tissue. Melanotan II is not approved for therapeutic use but is widely used by the general public. At Schedule 4 in the Poisons Standard, it is not banned by name in sport, but its anabolic effects might fall under the general “similarity of mechanism” clause.
Metabolic has just completed Phase IIA studies in a group of 22 clinically obese, but otherwise healthy, male patients ranging in age from 22?50. The results showed that the drug was well tolerated and increased fat metabolism within two hours of administration by 25 per cent in the older group of patients. Although not the focus of the study, weight loss was also demonstrated, particularly in the older group.
In a statement to Fairfax Media on Thursday, Calzada Ltd said: ''The US generally recognised as safe 'GRAS' status is being explored as another viable commercial path for the company to pursue to potentially derive early revenue. Whilst AOD-9604 was not successful in human trials aimed at obesity, the Company believes there is sufficient efficacy data to enable a potential food, drink or dietary supplement product to be successfully marketed in the US.''
After about a week of taking the collagen, I noticed my nails were thicker and stronger and were growing faster. Usually, my nails break and tear off after they grow, but after drinking my collagen, they were growing nicely and faster than normal. In fact, when I got a gel manicure, which is supposed to last up to two weeks, my nails grew out after about eight or nine days, leaving the bottoms of my nail beds exposed. Although it was annoying having to get my nails redone, it wasn’t a bad problem to have!
The original GRF (1-29) has a half-life of about 30 minutes. Half-life means the time within which half of the hormone administered will be destroyed within the body. This short half-life is due to the fact that the compound is highly unstable and breaks down soon. To increase its stability and to make it last longer, it was modified by adding 4 amino acids in its structure. This gave it the name Modified GRF (1-29) or Mod GRF 1-29. It was originally invented by DatBtrue. The portion of the molecule that actually stimulates the growth hormone secretion is found in the chain of 29 amino acids, so it is named GRF (1-29). This chemical also produces slow-wave sleep.

The mean time (± SD) taken for recovery of normal ambulation was 25±2 days in Group 1, 15±3 days in Group 2, 16±2 days in Group 3, and 11±4 days in Group 4. The lameness period in Group 4 was significantly shorter than those in Groups 1, 2, and 3 (p<0.05). The lameness period in Group 1 was significantly longer than those in Groups 2 and 3 (p<0.05). However, there were no differences in the mean lameness period between Groups 2 and 3 (Figure 6).
We identified 34 patients who met eligibility criteria based on the chart review. Two subjects were excluded because they were found to have diabetes requiring insulin therapy, 1 was excluded because of hypothyroidism, and 13 were excluded because they did not undergo gastric bypass surgery or did not wish to participate. A final study sample of 18 individuals (15 women) was enrolled into the protocol. We had 3 individuals who did not complete the 6‐month follow‐up visit; the sample that completed both visits consisted of 15 individuals (12 women). No subjects were excluded because of peri‐operative complications. Table 1 displays the characteristics of the study sample at baseline and 6 months after surgery. From baseline to 6 months after surgery, subjects had a mean decrease of 27% in body mass index (P<0.0001). There were significant reductions in mean arterial blood pressure (P=0.004) and heart rate (P<0.001) after surgery. Only 2 out of 18 subjects were on any class of anti‐hypertensive medications at the pre‐op visit before gastric bypass surgery. At the 6‐month visit, anti‐hypertensive medication was discontinued for one of these subjects, and continued at the same dose for the other subject. The mean±SD volume of saline infusion pre‐bypass was 2.6±0.4 L and post‐bypass was 2.3±0.3 L.
Best deal I found searching around. I plan to read up on datbtrue's forum once I get accepted. Right now I'm thinking wake up, and inject 500mcg, shower, hit the gym, leave do cardio, then eat. At night before bed inject another 500mcg. Not set in stone yet as I need to read up more, but this is what I'm thinking. Currently running cjc 1295 no dac, ghrp-2, and igf-1 LR3, Hup-a, and green tea extract.
The amazing effects of HCG on the hypothalamus were discovered by Dr. Albert T. W. Simeons in 1954, who observed that malnourished women tend to give birth to healthy babies with normal birth weights. Dr. Simeons concluded that women are able to do this because the HCG hormone that their bodies naturally produced during pregnancy helped their bodies to metabolise subcutaneous fat. hCG released by the embryo also helps women with weight redistribution (helps prevent uneven deposits of weight on thighs, abdomen, hips etc) and therefore women concerned with hormonal weight gain are ideal candidates for this diet.

AOD9604 is promoted heavily by various manufacturers as a substance that is able to burn fat and assist in the repair of muscle and cartilage. The fact that this product derives from, and claims to mimic the effects of a powerfully anabolic banned substance provides a psychological incentive to many potential users, as does the attention drawn by the AFL "peptides" scandal of early 2013 and the subsequent report by the Australian Crime Commission (1).
When you buy peptides online through Peptide Clinics you can be ensured of our commitment to your success. Peptide Clinics specialises in supplying premium peptide supplements, incorporated into custom treatment programs to assist you in meeting your health and fitness goals. All new client questionnaires are screened by one of our highly trained and experienced medical doctors. All initial and follow-up blood tests are also screened by our doctors, who use this information to recommend the peptide best suited for you, with its dose and frequency. Programs are customised on a per client basis dependent on your goals and blood test results, which are regularly reviewed and modified to ensure optimal peptide performance.
×